Lifeward Ltd. (LFWD)
NASDAQ: LFWD · Real-Time Price · USD
0.7170
+0.0111 (1.57%)
At close: Aug 13, 2025, 4:00 PM
0.6850
-0.0320 (-4.46%)
Pre-market: Aug 14, 2025, 9:24 AM EDT
Lifeward Revenue
Lifeward had revenue of $5.03M in the quarter ending March 31, 2025, a decrease of -4.71%. This brings the company's revenue in the last twelve months to $25.41M, up 41.92% year-over-year. In the year 2024, Lifeward had annual revenue of $25.66M with 85.24% growth.
Revenue (ttm)
$25.41M
Revenue Growth
+41.92%
P/S Ratio
0.26
Revenue / Employee
$317,675
Employees
80
Market Cap
11.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.66M | 11.81M | 85.24% |
| Dec 31, 2023 | 13.85M | 8.34M | 151.39% |
| Dec 31, 2022 | 5.51M | -455.00K | -7.63% |
| Dec 31, 2021 | 5.97M | 1.57M | 35.81% |
| Dec 31, 2020 | 4.39M | -480.00K | -9.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
LFWD News
- 1 hour ago - Lifeward Ltd. Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 1 day ago - Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership - GlobeNewsWire
- 6 days ago - Lifeward to Report Second Quarter Financial Results on August 14, 2025 - GlobeNewsWire
- 10 days ago - Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region - GlobeNewsWire
- 5 weeks ago - MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion - PRNewsWire
- 6 weeks ago - Lifeward Announces Closing of $2.6 Million Public Offering - GlobeNewsWire
- 7 weeks ago - Lifeward Announces Pricing of $2.6 Million Public Offering - GlobeNewsWire
- 7 weeks ago - Administrative Law Judge Determines ReWalk Personal Exoskeleton is “Reasonable and Necessary” for Medicare Beneficiary - GlobeNewsWire